- Home
- TRIB vs CRIS Comparison
TRIB vs CRIS Comparison
Compare TRIB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- CRIS
- Stock Information
- Founded
- TRIB 1992
- CRIS 2000
- Country
- TRIB Ireland
- CRIS United States
- Employees
- TRIB N/A
- CRIS N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRIB Health Care
- CRIS Health Care
- Exchange
- TRIB Nasdaq
- CRIS Nasdaq
- Market Cap
- TRIB 18.3M
- CRIS 18.6M
- IPO Year
- TRIB N/A
- CRIS 2000
- Fundamental
- Price
- TRIB $0.92
- CRIS $1.32
- Analyst Decision
- TRIB
- CRIS Strong Buy
- Analyst Count
- TRIB 0
- CRIS 2
- Target Price
- TRIB N/A
- CRIS $16.50
- AVG Volume (30 Days)
- TRIB 86.7K
- CRIS 74.5K
- Earning Date
- TRIB 11-14-2025
- CRIS 11-06-2025
- Dividend Yield
- TRIB N/A
- CRIS N/A
- EPS Growth
- TRIB N/A
- CRIS N/A
- EPS
- TRIB N/A
- CRIS N/A
- Revenue
- TRIB $61,555,000.00
- CRIS $11,405,000.00
- Revenue This Year
- TRIB $13.51
- CRIS $2.72
- Revenue Next Year
- TRIB $13.14
- CRIS $8.27
- P/E Ratio
- TRIB N/A
- CRIS N/A
- Revenue Growth
- TRIB 8.31
- CRIS 12.24
- 52 Week Low
- TRIB $0.48
- CRIS $1.02
- 52 Week High
- TRIB $3.44
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- TRIB 38.25
- CRIS 26.64
- Support Level
- TRIB $0.95
- CRIS $1.46
- Resistance Level
- TRIB $1.04
- CRIS $1.49
- Average True Range (ATR)
- TRIB 0.07
- CRIS 0.09
- MACD
- TRIB 0.00
- CRIS -0.02
- Stochastic Oscillator
- TRIB 27.93
- CRIS 11.63
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.